Avalide tablets contain a mixture of HydroDIURIL and irbesartan. HydroDIURIL could be a water pill water pill (water pill) that helps stop your body from engrossing an excessive amount of salt, which may cause fluid retention. Irbesartan is AN angiotensin II receptor antagonist. Irbesartan keeps blood vessels from narrowing, that lowers vital sign and improves blood flow.
Avalide is employed to treat high vital sign (hypertension).
Avalide may additionally be used for functions unlisted during this medication guide.
Submit your review
Get emergency medical help if you have any signs of an allergic reaction to Avalide: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
In rare cases, Avalide can cause a condition that results in the breakdown of skeletal muscle tissue, leading to kidney failure. Call your doctor right away if you have unexplained muscle pain, tenderness, or weakness especially if you also have fever, unusual tiredness, and dark colored urine.
Call your doctor at once if you have:
eye pain, vision problems;
a light-headed feeling, like you might pass out;
shortness of breath (even with mild exertion), swelling, rapid weight gain;
little or no urinating;
jaundice (yellowing of the skin or eyes); or
dry mouth, increased thirst, drowsiness, restless feeling, confusion, increased urination, fast heart rate, feeling light-headed, fainting, or seizure (convulsions).
Common Avalide side effects may include:
stomach pain, heartburn;
runny or stuffy nose, sore throat; or
Maximum antihypertensive effects are attained within 2 to 4 weeks after a change in dose. AVALIDE may be administered with or without food. AVALIDE may be administered with other antihypertensive agents. Renal impairment. The usual regimens of therapy with AVALIDE may be followed as long as the patient's creatinine clearance is >30 mL/min. In patients with more severe renal impairment, loop diuretics are preferred to thiazides, so AVALIDE is not recommended. Hepatic impairment. No dosage adjustment is necessary in patients with hepatic impairment.